NCT06771960
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Guangdong Provincial People's Hospital Guangzhou, Guangdong, China
Clinical trial condition
Lung Cancer (NSCLC)
Explore clinical trials studying Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.
98 public trials
43 recruiting studies
Lung Cancer (NSCLC) trial results
NCT06792435
- Conditions
- Adnexal Diseases, Biliary Tract Cancer, Biliary Tract Diseases, +35 more
- Locations
-
- Affiliated Hospital of Shandong First Medical University Jinan, Shandong, China
NCT06786468
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
- Locations
-
- Siriraj Hospital Bangkok, Thailand
Enrolling by Invitation
Effects of Immune Checkpoint Inhibitors on Coronary Microvasculature
NCT06332131
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +23 more
- Locations
-
- Abramson Cancer Center at University of Pennsylvania Philadelphia, Pennsylvania, United States
Enrolling by Invitation
Cryobiopsy Vs. Forceps Biopsy for Peripheral Pulmonary Lesions
NCT06752395
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Pusan National University Hospital Busan, South Korea
- Yeungnam University Medical Center Daegu, South Korea
- Chungnam National University Hospital Daejeon, South Korea
Not Yet Recruiting
Navigation Bronchoscopy Guided Microwave Ablation Versus SBRT in Early NSCLC
NCT07722182
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Prince of Wales Hospital Hong Kong
Not Yet Recruiting
Furmonertinib Plus Radiotherapy for EGFR+ NSCLC With Pleural Effusion
NCT07482605
- Conditions
- Adenocarcinoma, Adenocarcinoma of Lung, Bronchial Neoplasms, +18 more
- Locations
-
Not specified
Not Yet Recruiting
Perioperative Cemiplimab for Resectable Non-Small Cell Lung Cancer With High PD-L1
NCT07450183
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Henry Ford Health Detroit, Michigan, United States
Not Yet Recruiting
First-line Therapy With EGFR-TKI Combined With Trastuzumab Rezetecan for Advanced NSCLC Harboring EGFR Mutations Concomitant With HER2 Alterations
NCT07699952
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +10 more
- Locations
-
Not specified
Not Yet Recruiting
Olomorasib + Pembrolizumab KRAS G12C Mutant, PD-L1 TPS 1-49% Locally Advanced or Metastatic NSCLC
NCT07639242
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +11 more
- Locations
-
- University of North Carolina at Chapel Hill Chapel Hill, North Carolina, United States